You are not currently logged in.
Access JSTOR through your library or other institution:
If You Use a Screen ReaderThis content is available through Read Online (Free) program, which relies on page scans. Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Activation of Human Mitochondrial Pantothenate Kinase 2 by Palmitoylcarnitine
Roberta Leonardi, Charles O. Rock, Suzanne Jackowski and Yong-Mei Zhang
Proceedings of the National Academy of Sciences of the United States of America
Vol. 104, No. 5 (Jan. 30, 2007), pp. 1494-1499
Published by: National Academy of Sciences
Stable URL: http://www.jstor.org/stable/25426317
Page Count: 6
You can always find the topics here!Topics: Enzymes, Mitochondria, Mass spectroscopy, Proteins, Protein isoforms, Government regulation, Fluorescence, Line spectra, Humans, Neurodegenerative diseases
Were these topics helpful?See something inaccurate? Let us know!
Select the topics that are inaccurate.
Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Preview not available
The human isoform 2 of pantothenate kinase (PanK2) is localized to the mitochondria, and mutations in this protein are associated with a progressive neurodegenerative disorder. PanK2 inhibition by acetyl-CoA is so stringent (IC₅₀ < 1 μM) that it is unclear how the enzyme functions in the presence of intracellular CoA concentrations. Palmitoylcarnitine was discovered to be a potent activator of PanK2 that functions to competitively antagonize acetyl-CoA inhibition. Acetyl-CoA was a competitive inhibitor of purified PanK2 with respect to ATP. The interaction between PanK2 and acetyl-CoA was stable enough that a significant proportion of the purified protein was isolated as the PanK2·acetyl-CoA complex. The longchain acylcarnitine activation of PanK2 explains how PanK2 functions in vivo, by providing a positive regulatory mechanism to counteract the negative regulation of PanK2 activity by acetyl-CoA. Our results suggest that PanK2 is located in the mitochondria to sense the levels of palmitoylcarnitine and up-regulate CoA biosynthesis in response to an increased mitochondrial demand for the cofactor to support β-oxidation.
Proceedings of the National Academy of Sciences of the United States of America © 2007 National Academy of Sciences